- Trials with a EudraCT protocol (79)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
79 result(s) found for: Neuropsychological testing.
Displaying page 1 of 4.
EudraCT Number: 2010-020724-21 | Sponsor Protocol Number: ADR16SUS2 | Start Date*: 2011-04-06 |
Sponsor Name:Universitätsklinik für Neurologie, Medizinische Universität Wien | ||
Full Title: Amyloid Imaging with [11C]PIB PET and MRI in MCI – a pilot study | ||
Medical condition: Patients with Mild Cognitive Impairment (MCI) will be investigated with PIB PET to determin amyloid pathology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005971-18 | Sponsor Protocol Number: 13-617 | Start Date*: 2014-01-24 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: TimeToStop (TTS) Trial, A randomised controlled trial of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery | ||
Medical condition: We will investigate possible cognitive benifits of early antiepileptic drug withdrawal after pediatric epilepsy surgery. The concerning medical condition is refractory epilepsy | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004990-10 | Sponsor Protocol Number: MF/UME01 | Start Date*: 2012-01-09 |
Sponsor Name:Sahlgrenska Academy | ||
Full Title: Double-blind placebo controlled study of the effects of OSU6162 on chronic fatigue in patients who suffered a mild traumatic brain injury | ||
Medical condition: Mental fatigue after traumatic brain injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001916-37 | Sponsor Protocol Number: MATRICS_WP6-1 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:RADBOUD UNIVERSITY MEDICAL CENTER | |||||||||||||
Full Title: The neuropsychological characterization of aggressive behaviour in children and adolescents with Conduct Disorder or Oppositional Defiant Disorder (CD/ODD) | |||||||||||||
Medical condition: Aggressive behavior in children and adolescents with Conduct Disorder (CD) or Oppositional Defiant Disorder (ODD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001836-69 | Sponsor Protocol Number: Vort-MCI_001 | Start Date*: 2021-09-17 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Effects of Vortioxetine in Mild Cognitive Impairment measured by Functional Magnetic Resonance Imaging | ||
Medical condition: Mild cognitive impairment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003882-17 | Sponsor Protocol Number: MKM | Start Date*: 2013-05-06 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy subjects: a randomized, placebo-controlled, double-blind fMRI study. | ||
Medical condition: healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001481-25 | Sponsor Protocol Number: BorrSciWP2 | Start Date*: 2015-09-07 |
Sponsor Name:Sørlandet Sykehus HF | ||
Full Title: Lyme borreliosis; a scientific approach to reduce diagnostic and therapeutic uncertainties (BorrSci) WP2; SIX VERSUS TWO WEEKS TREATMENT WITH DOXYCYCLINE IN LYME NEUROBORRELIOSIS; A MULTICENTER,... | ||
Medical condition: Lyme Neuroborreliosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002481-32 | Sponsor Protocol Number: InflamAD | Start Date*: 2023-04-11 |
Sponsor Name:Amsterdam UMC VUmc | ||
Full Title: Imaging inflammation in Alzheimer's Disease | ||
Medical condition: Amyloid-beta positive individuals across the Alzheimer's disease continuum and amyloid-beta negative individuals without cognitive complaints | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001563-26 | Sponsor Protocol Number: NCT05355337 | Start Date*: 2022-10-03 | |||||||||||
Sponsor Name:Region Skåne | |||||||||||||
Full Title: Pramipexole for Anhedonic Depression (PRIME-PRAXOL) | |||||||||||||
Medical condition: The effect of nine weeks of treatment with the dopamine agonist Pramipexole in patients with depression with clinically significant anhedonia will be evaluated with symptom rating scales, blood and... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013400-31 | Sponsor Protocol Number: STEADI-09 | Start Date*: 2010-08-10 |
Sponsor Name:University of Southampton | ||
Full Title: A phase 2, double-blind, placebo-controlled study of the safety and tolerability of etanercept in patients with Alzheimer’s disease | ||
Medical condition: Alzheimer's disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003201-81 | Sponsor Protocol Number: GFVT01026904 (GACHE) | Start Date*: 2006-12-20 |
Sponsor Name:Universitätsklinikum Heidelberg | ||
Full Title: GACHE: German trial of Acyclovir and Corticosteroids in Herpes-simplex-virus-Encephalitis. A multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial. | ||
Medical condition: Herpes simplex virus type-1 (HSV-1) is the most frequent cause of fatal sporadic encephalitis in humans. Herpes simplex encephalitis (HSE) was one of the first viral infections to be successfully t... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003247-36 | Sponsor Protocol Number: HPN-100-005SE | Start Date*: 2015-02-10 |
Sponsor Name:Hyperion Therapeutics, Inc. | ||
Full Title: A Phase 2, Fixed-Sequence, Open-Label, Switch-Over Study of the Safety and Tolerability of HPN 100 Compared to Sodium Phenylbutyrate in Children 6–17 Years of Age with Urea Cycle Disorders, with a ... | ||
Medical condition: Urea Cycle Disorders | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2013-003390-95 | Sponsor Protocol Number: WN28745 | Start Date*: 2014-02-26 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A Phase III, randomized, double-blind, placebo-controlled, parallel-group, multicenter efficacy and safety study of Gantenerumab in patients with Mild Alzheimer’s disease: Part II: Open-label exten... | |||||||||||||
Medical condition: MILD ALZHEIMER’S DISEASE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) SE (Completed) ES (Completed) PT (Completed) IT (Completed) NL (Completed) BE (Completed) HU (Completed) FI (Completed) BG (Completed) DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004835-19 | Sponsor Protocol Number: 38RC16.015 | Start Date*: 2017-07-20 | |||||||||||
Sponsor Name:University Hospital Grenoble | |||||||||||||
Full Title: Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months | |||||||||||||
Medical condition: HSV encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000576-38 | Sponsor Protocol Number: CARL | Start Date*: 2022-06-08 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI CAMERINO | |||||||||||||
Full Title: Effect of treatment of the cholinergic precursor Choline Alfoscerate in mild cognitive dysfunction | |||||||||||||
Medical condition: Mild cognitive dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005416-15 | Sponsor Protocol Number: SIPA-SOS | Start Date*: 2016-10-20 |
Sponsor Name:Medical Center - University of Freiburg
[...]
1. Medical Center - University of Freiburg
2. Medical Center - University of Freiburg |
||
Full Title: An open label phase II study of Sirolimus in patients with segmental overgrowth syndrome | ||
Medical condition: Segmental overgrowth syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003410-15 | Sponsor Protocol Number: 6251 7976 | Start Date*: 2005-11-21 |
Sponsor Name:Neurology Unit | ||
Full Title: A twelve-month double-blind placebo-controlled cross-over study of the effect ofAricept treatment on cognitive dysfunction in multiple sclerosis. | ||
Medical condition: Multiple sclerosis is a devastating inflammation in the central nervous system and it can often give cognitive dysfunction, affecting memory, mental concentration. Lately it has been shown that the... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002702-12 | Sponsor Protocol Number: BN40031 | Start Date*: 2018-07-13 | |||||||||||
Sponsor Name:Roche Farma S.A.(Soc. Unipersonal)que realiza el ensayo en España y que actúa como representante F.Hodmann-La Roche LTD | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL, LONG-TERM EXTENSION OF PHASE III STUDIES (BN29552/BN29553) OF CRENEZUMAB IN PATIENTS WITH ALZHEIMER’S DISEASE | |||||||||||||
Medical condition: Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) LT (Prematurely Ended) GB (Prematurely Ended) SE (Prematurely Ended) DK (Prematurely Ended) FI (Prematurely Ended) HU (Completed) FR (Completed) BE (Completed) PL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005217-37 | Sponsor Protocol Number: I4O-MC-BACC(b) | Start Date*: 2012-08-22 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: Assessment of Safety, Tolerability, and Pharmacodynamic Effects of LY2886721 in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer's Disease | |||||||||||||
Medical condition: Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000453-35 | Sponsor Protocol Number: EPO-AD-01-2008 | Start Date*: 2008-06-30 | ||||||||||||||||
Sponsor Name:Max-Planck-Institute of Experimental Medicine | ||||||||||||||||||
Full Title: Open-label phase IIa pilot study exploring safety and potential efficacy of recombinant human erythropoietin in early mild Alzheimer Dementia and therapy-refractory Major Depression (“EPO-AD”) | ||||||||||||||||||
Medical condition: Early, mild dementia of the Alzheimer’s Type and therapy-refractory Major Depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
